Nanostics Inc. (CNW Group/Nanostics)
EDMONTON, June 4, 2019 /PRNewswire/ – Nanostics Inc., a company developing a novel liquid biopsy platform for the early diagnosis of clinically significant prostate cancer, is…
In Alberta, one in six men will be diagnosed with prostate cancer during their lifetime. When detected early, prostate cancer is one of the most successfully treated types of cancer.
The staff and volunteers at the Prostate Cancer Centre are dedicated to educating men about the importance of early detection.